1 / 6

Biopharmaceuticals Global Demand is Expected to Reach about $700 billion by 2030

The global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is projected to grow to $698.7 billion by 2030, with a CAGR of 9.2% during the forecast period 2024-2030. The biopharmaceutical market is fueled by the rising incidence of chronic illnesses, such as cancer, diabetes, heart disease, and autoimmune conditions, which need prolonged treatment. Governments worldwide are enhancing awareness and implementing strategies to promote the use of biopharmaceuticals, particularly for chronic, rare, and genetic diseases.

industryexperts
Download Presentation

Biopharmaceuticals Global Demand is Expected to Reach about $700 billion by 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biopharmaceuticals Global Demand is Expected to Witness Robust Growth at 9.2% to Reach about $700 billion by 2030

  2. A new report from Industry Experts, Inc. on "Biopharmaceuticals Market," is released. According to this global market research report, the global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is projected to grow to $698.7 billion by 2030, with a CAGR of 9.2% during the forecast period 2024-2030.

  3. The market for biopharmaceuticals analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

  4. Application – Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others (Including Metabolic Disorders, Blood Disorders and Others). The study analyzes the global market for biopharmaceuticals with respect to Product – Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals (including Blood Factors, Thrombolytic Agents, Interleukins, Tumor Necrosis Factor, and Therapeutic Enzymes)

  5. About Industry Experts, Inc. Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

More Related